On Monday, bulls dominated over the domestic markets as Sensex surged by 448.62 points or 1.12 per cent to settle at 40,431.60 levels while Nifty gained by 0.94 per cent or 110.60 points to close at 11,873.05 levels.

Zydus Cadila today announced that it has received tentative approval from USFDA to market Tofacitinib extended-release tablets, 11 mg (US RLD: Xeljanz XR® tablets).

Edelweiss Alternative Asset Advisors today announced the final close of its Rs 6,600 crore alternative investment fund - ESOF III.

Sirolimus tablets, 0.5 mg, 1 mg, and 2 mg are the generic version of Rapamune tablets, 0.5 mg, 1 mg, and 2 mg, of PF Prism CV. These tablets are used to prevent the rejection of kidney transplants.

Quant mutual fund has launched its newly open-ended equity scheme i.e. quant ESG Equity Fund. Read on to find more details.

The shares of Tata Communications have been locked at five per cent upper circuit. The stock is locked near the 52-week high of Rs 937 on BSE.

On Monday, Bank Nifty zoomed by around 2.17 per cent and S&P BSE Bankex was up by 2.37 per cent. While banking and financial stocks rally, SBI Cards, and its parent company, SBI is not shy of being favoured by the investors.

Dr Reddy’s and RDIF entered into a partnership in early September 2020 to conduct clinical trials and distribution of Sputnik V vaccine in India and as a part of it, RDIF would be delivering 100 million doses of the vaccine to Dr Reddy’s after receiving regulatory approval in India.

The market opened in green on October 19, 2020.

The market opened in green October 19, 2020, overall volumes in futures & options currently stand at 2,00,11,511 contracts with a turnover of Rs. 14,48,499.97 crore.